Canadian Urological Association (CUA)

V2P2 2022 - An Update in Advanced Prostate Cancer

Episode Summary

V2P2 2022 - An Update in Advanced Prostate Cancer

Episode Notes

Disclosures:

Fred Saad
Grants/Honoraria: Amgen, Astellas, AstraZeneca, Bayer, Merck, Novartis, Janssen, Myovant, Sanofi

Eleni Efstathiou
Research Support/P.I.: Janssen, Sanofi-Genzyme, Astellas/Medivation, Oric-Pharma, Nuvation
Scientific Advisory Board/Honoraria: Janssen, Sanofi-Genzyme, Bayer, Oric Pharma, Marck, AAA-Novartis, Genetech, Astra-Zeneca, Astellas, Pfizer, Myovant